104 related articles for article (PubMed ID: 16547938)
1. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention.
Ellis SG; Bhatt D; Kapadia S; Lee D; Yen M; Whitlow PL
Catheter Cardiovasc Interv; 2006 Apr; 67(4):541-5. PubMed ID: 16547938
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.
Farouque HM; Tremmel JA; Raissi Shabari F; Aggarwal M; Fearon WF; Ng MK; Rezaee M; Yeung AC; Lee DP
J Am Coll Cardiol; 2005 Feb; 45(3):363-8. PubMed ID: 15680713
[TBL] [Abstract][Full Text] [Related]
3. Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention.
Tiroch KA; Arora N; Matheny ME; Liu C; Lee TC; Resnic FS
Am J Cardiol; 2008 Dec; 102(11):1473-6. PubMed ID: 19026298
[TBL] [Abstract][Full Text] [Related]
4. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
[TBL] [Abstract][Full Text] [Related]
6. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
Karha J; Gurm HS; Rajagopal V; Fathi R; Bavry AA; Brener SJ; Lincoff AM; Ellis SG; Bhatt DL
Am J Cardiol; 2006 Oct; 98(7):906-10. PubMed ID: 16996871
[TBL] [Abstract][Full Text] [Related]
7. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication.
Sreeram S; Lumsden AB; Miller JS; Salam AA; Dodson TF; Smith RB
Am Surg; 1993 Feb; 59(2):94-8. PubMed ID: 8476149
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of the management of retro-peritoneal bleeding after percutaneous coronary intervention in the era of combination anti-platelet therapy.
Foley P
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):56-8. PubMed ID: 18268420
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
12. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
Fuchs S; Kornowski R; Teplitsky I; Brosh D; Lev E; Vaknin-Assa H; Ben-Dor I; Iakobishvili Z; Rechavia E; Battler A; Assali A
Cardiovasc Revasc Med; 2009; 10(2):88-93. PubMed ID: 19327670
[TBL] [Abstract][Full Text] [Related]
13. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
Trimarchi S; Smith DE; Share D; Jani SM; O'Donnell M; McNamara R; Riba A; Kline-Rogers E; Gurm HS; Moscucci M;
JACC Cardiovasc Interv; 2010 Aug; 3(8):845-50. PubMed ID: 20723857
[TBL] [Abstract][Full Text] [Related]
14. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.
Berger JS; Sanborn TA; Sherman W; Brown DL
Am Heart J; 2006 May; 151(5):1026-31. PubMed ID: 16644329
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
[TBL] [Abstract][Full Text] [Related]
16. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
[TBL] [Abstract][Full Text] [Related]
17. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
19. Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy).
Sciahbasi A; Pristipino C; Ambrosio G; Sperduti I; Scabbia EV; Greco C; Ricci R; Ferraiolo G; Di Clemente D; Giombolini C; Lioy E; Tubaro M
Am J Cardiol; 2009 Mar; 103(6):796-800. PubMed ID: 19268734
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
